States to receive funds from diabetes-drug suit

BOSTON – Attorney General Martha Coakley’s office announced last week that it had joined 37 other states in a $90 million settlement with GlaxoSmithKline LLC. The lawsuit resolves allegations that the pharmaceutical company unlawfully promoted its diabetes drug, Avandia, by misrepresenting its cardiovascular risks and safety profile. According to a statement, the settlement will bring more than $2.1 million to the commonwealth. More

This item is available in full to subscribers. If you are a current subscriber, log in to continue.

Otherwise, purchase a subscription to continue.

You can also purchase this single article, if you prefer. Click here to continue.